I read with great interest the Commentary "Conflicts of Interest: Science, Money, and Health"1 published in the March 25, 2002, issue of the ARCHIVES. I agree wholeheartedly that conflicts of interest need to be better clarified for the reader of the medical literature especially when it pertains to industry-sponsored trials. I would, however, like to highlight additional issues that need to be addressed by recommendations governing the publishing of industry-sponsored trials in peer-reviewed journals.
LaRosa SP. Conflict of Interest: Authorship Issues Predominate. Arch Intern Med. 2002;162(14):1646. doi: